Integrated Biopharma Balance Sheet - Annual (OTCMKTS:INBP)

Add to My Stocks
$0.16 $0 (0%) INBP stock closing price Sep 21, 2018 (Closing)

The Integrated Biopharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. As in our Integrated Biopharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Integrated Biopharma revenue Integrated Biopharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Integrated Biopharma balance sheet for 2017 shows cash on hand of $-. The company has a debt to equity ratio of -.

View latest 10 year balance sheet data to check Integrated Biopharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jul - Jun201720162015201420132012201120102009
Marketable Securities---------
Raw Materials3.84M4.04M2.37M2.85M2.51M2.5M2.56M2.53M2.13M
Work In Progress1.96M2.21M2.06M1.21M1.97M1.34M1.05M1.39M-
Finished Goods1.83M1.5M1.34M1.63M1.94M1.44M1.74M3.05M5M
Notes Receivable---------
Other Current Assets------3.89M--
Total Current Assets
Property Plant & Equipment8.3M8M7.78M7.54M7.35M7.45M7.13M7.21M7.21M
Accumulated Depreciation6.7M6.44M6.41M6.3M6.12M6M5.53M5.49M5.34M
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable4.67M4.21M4.46M4.12M4.54M1.49M12.6M11.74M7.45M
Accounts Payable4.17M5.46M5.14M5.63M5.88M6.48M5.15M6.44M5.78M
Current Portion Long-Term Debt1.11M----2.67M---
Current Portion Capital Leases---------
Accrued Expenses1.18M1.21M1.53M1.3M1.12M1.54M-1.35M1.44M
Income Taxes Payable---------
Other Current Liabilities------2.66M--
Total Current Liabilities
Deferred Taxes/Income---------
Convertible Debt5.22M5.2M5.12M5M4.9M4.79M--4.03M
Long-Term Debt4.24M5.3M3.94M4.35M4.88M4.69M---
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus44.75M44.7M44.67M44.57M44.56M44.56M44.54M44.26M44.21M
Retained Earnings-50.63M-52.97M-53.93M-54.67M-54.8M-54.89M-52.18M-49.9M-46.6M
Treasury Stock---------
Other Liabilities---------
Shareholders Equity-5.92M-8.32M-9.31M-10.15M-10.29M-10.38M-7.69M-5.69M-2.44M
Total Liabilities & Shareholders Equity15.19M14.08M11.62M11.58M12.61M11.87M13.65M13.84M16.48M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Integrated Biopharma stock price by looking at Integrated Biopharma historical stock prices. One can compare PE with industry average by looking at the Integrated Biopharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Integrated Biopharma owns and has monetary significance. INBP assets grew from $14.08M in 2016 to $15.19M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of Integrated Biopharma for the year 2017 total to $21.12M. Liabilities for a company like Integrated Biopharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Integrated Biopharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover